The State Bank of India is looking to raise around 50 billion rupees ($573.38 million) via Basel III-compliant additional ...

US imports surged to a record high in December, official figures showed today as Donald Trump’s threat of tariffs triggered a ...

The company reported full-year revenue of $40.5 billion, up 25% compared to 2023. For the fourth quarter, Novo reported $11.6 billion in revenues, up 30% compared to the same quarter in 2023.

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep rising through the end of the decade as it boosts production of ...

Novo executives were keen to speak on Wegovy’s growing success during the company’s earnings call Wednesday, with David Moore, the drugmaker’s head of U.S. operations and global business ...

The Indian Hotels Company is investing Rs 2,500 crore to develop a new 330-room Taj Bandstand property in Mumbai. The ...

As a pioneer in diabetes care, Novo has been in the business for over 85 years and claims 34% of the $80 billion-plus diabetes treatment market and roughly half of the more than $15 billion ...

Novo Nordisk AS (NYSE:NVO) reported a strong 26% sales growth and 26% operating profit growth for 2024. The company expanded its patient reach, now serving over 45 million patients with diabetes ...

Novo said fourth-quarter operating profit jumped 37% to 36.7 billion Danish crowns ($5.12 billion), better than the 33.6 billion forecast by analysts in a company poll. It predicted operating ...

Novo Nordisk has achieved another blockbuster financial year as the group cheered intense global demand for its obesity and diabetes drugs. The Danish pharmaceutical giant reported turnover from ...

Ozempic, which accounts for 41 per cent of the company's sales, is an injectable anti-diabetic treatment that became wildly popular on social networks for its slimming properties. Novo Nordisk ...